In bladder cancer patients, the majority of EGF and EGFR alterations are mRNA upregulation and amplification (Fig. 2), which led to an upregulation of their expression associated with the progression in bladder cancer 30, 31, 32. The gene discussed is EGF; the disease is urinary bladder carcinoma.